Provectus Biopharmaceuticals (PVCT) Share-based Compensation (2010 - 2026)
Provectus Biopharmaceuticals (PVCT) posted Share-based Compensation of $287,601 for Q4 2025, down 8.0% from the prior quarter.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Share-based Compensation (2010 - 2026) Analysis & Trends
For FY2025, Provectus Biopharmaceuticals' Share-based Compensation came in at $1.24 million, down 3.4% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 55.8% (FY2020 to FY2025).
- In prior years, Provectus Biopharmaceuticals' Share-based Compensation was $1.28 million in FY2024, $2,850 in FY2023 (-5.8%), $3,025 in FY2022 (-87.2%) and $23,688 in FY2021 (-82.4%).
- The Q4 2025 figure stands as the lowest quarterly Share-based Compensation since Q3 2021.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $312,775 (Q3 2025), $322,070 (Q2 2025) and $315,100 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 305,944.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 305,944.00 |
| Dec 31, 2025 | 287,601.00 |
| Sep 30, 2025 | 312,775.00 |
| Jun 30, 2025 | 322,070.00 |
| Mar 31, 2025 | 315,100.00 |
| Dec 31, 2024 | 331,371.00 |
| Sep 30, 2024 | 949,405.00 |
| Sep 30, 2021 | 1,775.00 |
| Jun 30, 2021 | 2,163.00 |
| Mar 31, 2021 | 19,750.00 |
| Dec 31, 2020 | 129,926.00 |
| Sep 30, 2020 | 3,678.00 |
| Dec 31, 2019 | 1,239.00 |
| Sep 30, 2019 | 2,665.00 |
| Jun 30, 2019 | 16,425.00 |
| Mar 31, 2019 | 2,650.00 |
| Dec 31, 2015 | 472,882.00 |
| Sep 30, 2015 | 24,262.00 |
| Jun 30, 2015 | 53,582.00 |
| Mar 31, 2015 | 1,632.00 |
API Access
Provectus Biopharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();